Axitinib
10852
Phase 2 small_molecule completed
Quick answer
Axitinib for Melanoma is a Phase 2 program (small_molecule) at ADIAL PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ADIAL PHARMACEUTICALS, INC.
- Indication
- Melanoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed